Related Experiment Videos
[P53 in atherosclerotic plaques]
1Cardiovascular Institute, Beijing Medical University.
Zhonghua Yi Xue Za Zhi
|November 1, 1993
Abstract:
The methylation and expression of P53 were studied in atherosclerotic plaques. Atherosclerosis was initiated in 2.5-3.0 kg New Zealand white Rabbits by feeding cholesterol, oil and endothelial debridement of the aorta. There were the methylation of the partial CCGG sites, low levels of expression of the wild-type P53 and mutant P53 protein in the plaques. These might be an important cause of the cellular proliferation during development of atherosclerosis.
Insights
Methylation and reduced expression of P53 were observed in atherosclerotic plaques. This may drive cellular proliferation in atherosclerosis development.
Area of Science:
- Molecular biology
- Cardiovascular research
- Epigenetics
Context:
- Atherosclerosis is a chronic inflammatory disease characterized by plaque buildup in arteries.
- The p53 tumor suppressor protein plays a critical role in cellular responses to stress and DNA damage.
Purpose:
- To investigate the methylation status and expression levels of p53 in experimentally induced atherosclerotic plaques.
- To explore the potential role of p53 alterations in the pathogenesis of atherosclerosis.
Summary:
- Atherosclerosis was induced in New Zealand white rabbits via a high-cholesterol diet and endothelial debridement.
- Analysis revealed partial methylation of CCGG sites and decreased expression of both wild-type and mutant p53 proteins within the atherosclerotic plaques.
- These epigenetic and expression changes in p53 may contribute to the observed cellular proliferation during atherosclerosis development.
Impact:
- Provides insights into the molecular mechanisms underlying atherosclerosis.
- Suggests a potential link between p53 dysregulation and the proliferative phase of atherosclerotic plaque formation.
- Highlights the role of epigenetic modifications in cardiovascular disease pathogenesis.